Anticipation Mounting Over Expected WHO Senior Leadership Reshuffle 07/10/2022 Elaine Ruth Fletcher World Health Organization Chief Scientist Dr Soumya Swaminathan, a respected voice in WHO’s senior leadership is expected to resign within the next month – in the first major leadership shuffle by Director General Dr Tedros Adhanom Ghebreyesus since the COVID-19 pandemic began, Health Policy Watch has learned. Conversely, Dr Mike Ryan, executive director of WHO’s […] Continue reading -> Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Tedros’ Second Term: WHO’s Triple Billion Goals Fall Short as Agency Sees Power Centralized, Over-Reliance on Consultants 26/08/2022 Elaine Ruth Fletcher “Power has been increasingly centralised around the Director-General’s office under Tedros’ leadership. This strategy might be advantageous in a crisis that demands a commander-in-control. But a lack of depth in wider leadership leaves shortcomings in the organisation. Thus states the prestigious medical journal, The Lancet, in an editorial marking the start of WHO Director General Dr Tedros […] Continue reading -> W. Africa’s Polluted Air 2nd Only to S. Asia 17/08/2022 John Heilprin & Elaine Ruth Fletcher Some 1.7 million people in cities across the planet died from polluted air in 2019, according to the first-ever study of urban air pollution that covers virtually every city in the world over the size of 50,000 people, as per the UN definition. Conditions are the most severe in cities of South Asia, (WHO’s SouthEast […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Tedros’ Second Term: WHO’s Triple Billion Goals Fall Short as Agency Sees Power Centralized, Over-Reliance on Consultants 26/08/2022 Elaine Ruth Fletcher “Power has been increasingly centralised around the Director-General’s office under Tedros’ leadership. This strategy might be advantageous in a crisis that demands a commander-in-control. But a lack of depth in wider leadership leaves shortcomings in the organisation. Thus states the prestigious medical journal, The Lancet, in an editorial marking the start of WHO Director General Dr Tedros […] Continue reading -> W. Africa’s Polluted Air 2nd Only to S. Asia 17/08/2022 John Heilprin & Elaine Ruth Fletcher Some 1.7 million people in cities across the planet died from polluted air in 2019, according to the first-ever study of urban air pollution that covers virtually every city in the world over the size of 50,000 people, as per the UN definition. Conditions are the most severe in cities of South Asia, (WHO’s SouthEast […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tedros’ Second Term: WHO’s Triple Billion Goals Fall Short as Agency Sees Power Centralized, Over-Reliance on Consultants 26/08/2022 Elaine Ruth Fletcher “Power has been increasingly centralised around the Director-General’s office under Tedros’ leadership. This strategy might be advantageous in a crisis that demands a commander-in-control. But a lack of depth in wider leadership leaves shortcomings in the organisation. Thus states the prestigious medical journal, The Lancet, in an editorial marking the start of WHO Director General Dr Tedros […] Continue reading -> W. Africa’s Polluted Air 2nd Only to S. Asia 17/08/2022 John Heilprin & Elaine Ruth Fletcher Some 1.7 million people in cities across the planet died from polluted air in 2019, according to the first-ever study of urban air pollution that covers virtually every city in the world over the size of 50,000 people, as per the UN definition. Conditions are the most severe in cities of South Asia, (WHO’s SouthEast […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
W. Africa’s Polluted Air 2nd Only to S. Asia 17/08/2022 John Heilprin & Elaine Ruth Fletcher Some 1.7 million people in cities across the planet died from polluted air in 2019, according to the first-ever study of urban air pollution that covers virtually every city in the world over the size of 50,000 people, as per the UN definition. Conditions are the most severe in cities of South Asia, (WHO’s SouthEast […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Records World’s Highest Gain in Healthy Life Expectancy Over Past Decade 04/08/2022 Paul Adepoju & Elaine Ruth Fletcher Africa recorded the world’s highest gain in healthy life expectancy over the past decade. But the lack of sustainable finance for health systems is a major threat to the gains recorded. Africa recorded the world’s highest growth in healthy life expectancy—or the number of years an individual is in a good state of health—between 2000 […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Posts navigation Older postsNewer posts